SciSparc Completes Acquisition Of Wellution

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,

SciSparc Ltd. (NASDAQ:SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced the closing of the definitive agreements for its acquisition of Wellution™, a top- seller Amazon.com Marketplace (“Amazon”) account, American food supplements and cosmetics brand and trademark (the “Acquisition” and the “Brand”, respectively). In connection with the Acquisition, the Company has incorporated a new wholly owned Delaware subsidiary, SciSparc Nutraceuticals Inc., to hold the new assets. The definitive agreement for the acquisition of the Brand was entered into with Merhavit M.R.M Holding and Management Ltd (“M.R.M”).

Total
0
Shares
Related Posts
Read More

Uranium Energy Announced Thursday it Received a Notice From UEX Corporation That Denison Mines Has Made an Acquisition Proposal for All of the Issued and Outstanding Shares of UEX

Uranium Energy Corp. (NYSE: UEC) (the "Company" or "UEC") announces that it has received a notice from UEX Corporation ("UEX") that Denison Mines Corp. ("Denison") has made an acquisition proposal for all of the issued and outstanding shares of UEX (the "Denison Proposal") pursuant to a plan of arrangement.

DNN